S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

DAWN Day One Biopharmaceuticals Inc

13.98

0.64 (4.80%)

23 Nov 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Day One Biopharmaceuticals (NASDAQ:DAWN)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Day One Biopharmaceuticals Charts.

Day One Biopharmaceuticals (NASDAQ:DAWN)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Day One Biopharmaceuticals Charts.

Day One Biopharmaceuticals Inc News

Form 8-K - Current report
Thursday 21 November 2024 (3 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 20 November 2024 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 20 November 2024 (4 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 19 November 2024 (5 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 19 November 2024 (5 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 13 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 12 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 1 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 31 October 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 31 October 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 13 September 2024 (2 months ago) • Edgar (US Regulatory)

More Day One Biopharmaceuticals Inc News Articles

Invesco QQQ Trust Series 1

National Australia Bank

Australia And New Zealan...

Woodside Petroleum

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions